These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11020603)

  • 1. New pieces for the puzzle: nonsteroidal anti-inflammatory drugs and corneal ulcers.
    Price FW
    J Cataract Refract Surg; 2000 Sep; 26(9):1263-5. PubMed ID: 11020603
    [No Abstract]   [Full Text] [Related]  

  • 2. Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs.
    Guidera AC; Luchs JI; Udell IJ
    Ophthalmology; 2001 May; 108(5):936-44. PubMed ID: 11320025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of matrix metalloproteinases in ulcerative keratolysis associated with perioperative diclofenac use.
    O'Brien TP; Li QJ; Sauerburger F; Reviglio VE; Rana T; Ashraf MF
    Ophthalmology; 2001 Apr; 108(4):656-9. PubMed ID: 11297478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corneal ulceration and perforation with ketorolac tromethamine.
    Lee WB; Himmel K
    Cornea; 2006 Dec; 25(10):1268. PubMed ID: 17172920
    [No Abstract]   [Full Text] [Related]  

  • 5. [Should Helicobacter pylori infection be taken into account in the use of nonsteroidal anti-inflammatory agents?].
    Bretagne JF; Pagenault M; Bourienne A; Heresbach D
    Gastroenterol Clin Biol; 1999 Oct; 23(10 Pt 2):C48-64. PubMed ID: 10880915
    [No Abstract]   [Full Text] [Related]  

  • 6. Anaphylactoid reaction to a cyclooxygenase-2 inhibitor in a patient who had a reaction to a cyclooxygenase-1 inhibitor.
    Schellenberg RR; Isserow SH
    N Engl J Med; 2001 Dec; 345(25):1856. PubMed ID: 11752370
    [No Abstract]   [Full Text] [Related]  

  • 7. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?
    Feldman M; McMahon AT
    Ann Intern Med; 2000 Jan; 132(2):134-43. PubMed ID: 10644275
    [No Abstract]   [Full Text] [Related]  

  • 8. COX-2-specific inhibitor or proton pump inhibitor plus traditional NSAID: is either approach sufficient for patients at highest risk of NSAID-induced ulcers?
    Cryer B
    Gastroenterology; 2004 Oct; 127(4):1256-8. PubMed ID: 15481002
    [No Abstract]   [Full Text] [Related]  

  • 9. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS
    JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celecoxib versus diclofenac and omeprazole to prevent recurrent ulcer bleeding.
    Lanas A
    N Engl J Med; 2003 Jun; 348(24):2464-6; author reply 2464-6. PubMed ID: 12802035
    [No Abstract]   [Full Text] [Related]  

  • 11. [In vivo selectivity of nonsteroidal anti-inflammatory drugs on COX-1-COX-2 and gastrointestinal ulcers, in rats].
    Laudanno OM; Cesolari JA; Esnarriaga J; Flaherty P; Vada J; Guastalli G; San Miguel P; Bedini OA
    Acta Gastroenterol Latinoam; 1998; 28(3):249-55. PubMed ID: 9773153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery.
    Lin JC; Rapuano CJ; Laibson PR; Eagle RC; Cohen EJ
    Arch Ophthalmol; 2000 Aug; 118(8):1129-32. PubMed ID: 10922213
    [No Abstract]   [Full Text] [Related]  

  • 13. Nonsteroidal anti-inflammatory drugs and Alzheimer disease: what's next?
    Launer LJ
    JAMA; 2003 Jun; 289(21):2865-7. PubMed ID: 12783919
    [No Abstract]   [Full Text] [Related]  

  • 14. Corneal sensitivity debate.
    Villain M; Trinquand C; Arnaud B
    Arch Ophthalmol; 1997 May; 115(5):686. PubMed ID: 9152147
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical approach for the patient requiring non-steroid anti-inflammatory agents: role of COX-2 inhibitors].
    Lanas A; Piqué JM; Ponce J;
    Gastroenterol Hepatol; 2001 Jan; 24(1):22-36. PubMed ID: 11219137
    [No Abstract]   [Full Text] [Related]  

  • 16. Coming: a review of second-generation nonsteroidal anti-inflammatory drugs.
    Housholder GT; Chan JT
    J Gt Houst Dent Soc; 1997 Mar; 68(8):13-6. PubMed ID: 9594801
    [No Abstract]   [Full Text] [Related]  

  • 17. [Arthrosis drugs critically evaluated. Emphasis on cartilage protection].
    Wepner U
    MMW Fortschr Med; 2002 Mar; 144(13):4-8. PubMed ID: 12001589
    [No Abstract]   [Full Text] [Related]  

  • 18. COX-1 and COX-2 in health and disease.
    Adelizzi RA
    J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S7-12. PubMed ID: 10643175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Benefits and risks of cyclooxygenase-2-selective inhibitor nonsteroidal antiinflammatory drugs].
    Vallano A; Llop R; Bosch M
    Med Clin (Barc); 2002 Oct; 119(11):429-34. PubMed ID: 12381279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.